Diclofenac topical - Novartis

Drug Profile

Diclofenac topical - Novartis

Alternative Names: Diclofenac sodium gel 1% - Novartis; Voltaren Gel

Latest Information Update: 20 May 2017

Price : $50

At a glance

  • Originator Novartis
  • Class Antipyretics; Antirheumatics; Non-opioid analgesics; Nonsteroidal anti-inflammatories; Phenylacetates; Small molecules
  • Mechanism of Action Arachidonic acid inhibitors; Cyclooxygenase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Musculoskeletal pain
  • Phase III Acute pain

Most Recent Events

  • 24 Mar 2016 First generic equivalent is available in USA
  • 14 Dec 2015 Endo extends its license with Novartis diclofenac topical in United States
  • 21 Apr 2015 No recent reports of development identified - Phase-III for Musculoskeletal pain in Germany (Topical)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top